SCHEMBL28114718

SCHEMBL28114718

COC(=O)c1sccc1CCCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
CYP4A11 Q02928 2/20 0.49
MEN1 O00255 3/20 0.48
CYP1A2 P05177 1/20 0.48
NPC1 O15118 1/20 0.45
CYP4F2 P78329 1/20 0.44
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPK10 P53779 5/20 0.43
MAPK8 P45983 3/20 0.43
MAPK9 P45984 3/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
TSHR P16473 1/20 0.42
NLRP1 Q9C000 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8636706 0.90 KMT2A (0.53) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL28763196 0.87 KMT2A (0.54) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL6621712 0.86 KMT2A (0.49) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL13098077 0.86 KMT2A (0.53) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL23142270 0.86 KMT2A (0.49) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL6625082 0.83 KMT2A (0.57) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL4683311 0.83 KMT2A (0.56) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL8634771 0.82 KMT2A (0.51) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL27485588 0.82 KMT2A (0.51) KMT2AMEN1CYP1A2NPC1HPGD
SCHEMBL13098618 0.82 LTB4R (0.56) KMT2ANPC1SMN1; SMN2MAPK10MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104583201-B Difluorolactam compounds as EP4 receptor selective agonists for use in the treatment of EP4 mediated diseases and conditions 开曼化学股份有限公司 2016-12-14 CN disclosed